No one has had a Synchron brain-computer interface longer than Rodney Gorham. He’s still finding new ways to use it.

Neuralink made history with its first human implant — but it's not the only player. Here's where brain-computer interface technology actually stands in 2026.

Researchers monitored participants for one year and found the device to be safe, with no serious adverse events that led to disability or death. Stentrode™ also stayed in place for all four patients ...

Synchron’s brain computer interface (BCI) device caused no deaths or permanent increases in disability in the first year of a U.S. clinical trial, the company said Monday. The study enrolled six ...

The early feasibility study (EFS), funded by the National Institutes of Health (NIH), will primarily assess safety and begin to explore quantified efficacy measures of Synchron’s Stentrode™ in ...

In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

Brain-computer interfaces, like Synchron's Stentrode device, could empower millions of disabled people to more easily communicate and engage in modern life Author of the article: You can save this ...

DelveInsight's Implanted Brain-Computer Interface Devices Market Insights report provides the current and forecast market ...

The implanted brain-computer interface devices market growth is largely propelled by the rising incidence of neurological and movement disorders, along with an increasing population affected ...

China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.

Medical device leaders who have built and scaled category-defining products join Synchron to help drive its next-generation brain-computer interface platform as well as accelerate towards ...